Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The opsin receptor family encompasses a large, diverse group of G protein-coupled receptors (GPCRs) that are sensitive to light due to a covalently bound chromophore, typically retinal[1][2][3][7]. Opsins have a canonical seven-transmembrane-domain structure and are primarily responsible for light detection (photoreception) in animal vision, but also play roles in non-visual photoreception such as circadian rhythm regulation[2][3][6][7]. Phylogenetically, the opsin family is subdivided into at least seven functional and molecular subfamilies, including vertebrate visual opsins, non-visual opsins, melanopsins, peropsins, neuropsins, encephalopsins (also called tmt-opsins), and retinal photoisomerases[1][3][6]. Opsins transduce light signals by activating specific G proteins, initiating downstream signaling pathways to convert photon absorption into physiological responses[3][6]. Mutations or dysfunction of opsins are linked to various visual disorders and some non-visual biological disruptions[6]. Notes on correctness: - The term "opsin receptor family" is too broad/generic; it refers to a large and evolutionarily diverse group rather than a single molecular target. For more structured information (such as interacting drugs or specific disease links), one would need to specify the particular opsin (e.g., rhodopsin, melanopsin)[1][2][3][6]. - "Opsin" is sometimes used interchangeably for multiple gene/protein products; standardization on a specific opsin is necessary for detailed therapeutic or pharmacological information.
Activation of G-protein signaling in response to light via chromophore (retinal) binding
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Opsin receptor.